ClinVar Miner

Submissions for variant NM_002029.4(FPR1):c.634G>A (p.Ala212Thr)

gnomAD frequency: 0.00006  dbSNP: rs765164623
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002241504 SCV001409959 uncertain significance Gingival disorder 2019-10-30 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in an individual affected with periodontitis (PMID: 17927965). This variant is present in population databases (rs765164623, ExAC 0.001%). This sequence change replaces alanine with threonine at codon 212 of the FPR1 protein (p.Ala212Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.